Trial Information

Official Title: Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies

Summary

The purpose of this study is to evaluate if a drug commonly used to treat excessive day-time sleepiness, called armodafinil (Nuvigil), is also effective in improving the impairment in the attention commonly reported by patients with more advanced Parkinson's disease (PD) and Lewy body disease (LBD).

Phase: N/A

Sponsor: New York University

Overall Contacts:

Sara Varanese, M.D.
212-263-4838 ext. 3
sara.varanese@nyumc.org

Jamika Y. Singleton-Garvin
Phone: 212-263-7042
Jamika.Singleton-Garvin@nyumc.org